Anzeige
Mehr »
Dienstag, 25.08.2026 - Börsentäglich über 12.000 News
NurExone Biologic: Der CEO legt die Karten auf den Tisch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40CM8 | ISIN: KYG3314S1066 | Ticker-Symbol: 5UD
Frankfurt
24.08.26 | 15:25
0,072 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
FANGZHOU INC Chart 1 Jahr
5-Tage-Chart
FANGZHOU INC 5-Tage-Chart

Aktuelle News zur FANGZHOU Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
17.08.FANGZHOU JIANKE (06086): DATE OF BOARD MEETING2
21.07.EQS Newswire: Wuhan Queqi Culture Media: 'Grandpa Sugar Pill' Honored at UNESCO Headquarters Centenary Commemoration of Gu Fangzhou Held in France677EQS Newswire / 21/07/2026 / 10:22 UTC+8 On July 16, the launch ceremony of the event themed A Century of Legacy, A Future of Shared Prosperity - Commemorative Event for the 100th Anniversary of...
► Artikel lesen
20.07.Start von Novo Nordis Medikament treibt Fangzhou Aktie an53
FANGZHOU Aktie jetzt für 0€ handeln
20.07.Fangzhou Inc.: Fangzhou Launches Novo Nordisk's Once-Weekly Basal Insulin/GLP-1 Therapy in China2.133SHANGHAI, July 20, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, announced the launch of Kyinsu®...
► Artikel lesen
09.07.Fangzhou Inc.: Fangzhou Named to KPMG China Healthcare 50 for AI-Powered Chronic Disease Care2
17.06.FANGZHOU JIANKE (06086): AMENDED AND RESTATED ARTICLES OF ASSOCIATION-
17.06.FANGZHOU JIANKE (06086): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS1
17.06.FANGZHOU JIANKE (06086): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, JUNE 16, 20262
22.05.FANGZHOU JIANKE (06086): INVITATION LETTER TO REGISTERED SHAREHOLDERS FOR ONLINE ATTENDANCE AT 2026 ANNUAL GENERAL MEETING-
22.05.FANGZHOU JIANKE (06086): INVITATION LETTER TO NON-REGISTERED HOLDERS FOR ONLINE ATTENDANCE AT 2026 ANNUAL GENERAL MEETING-
22.05.FANGZHOU JIANKE (06086): FORM OF PROXY ANNUAL GENERAL MEETING TO BE HELD ON JUNE 16, 2026 OR ANY ADJOURNMENT OR POSTPONEMENT THEREOF-
22.05.FANGZHOU JIANKE (06086): PROPOSALS FOR GENERAL MANDATE TO ISSUE SHARES AND REPURCHASE MANDATE TO REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS ...-
22.05.FANGZHOU JIANKE (06086): NOTICE OF ANNUAL GENERAL MEETING1
22.05.FANGZHOU JIANKE (06086): PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND ADOPTION OF THE AMENDED AND RESTATED ARTICLES OF ASSOCIATION1
19.05.Fangzhou Inc.: Fangzhou Ranked among 2025 Guangzhou AI Innovation "Most Promising Enterprises" for AI-Powered Chronic Disease Services1
14.05.Fangzhou und Tenry Pharmaceutical kooperieren bei KI-gestütztem Diabetes-Management1
14.05.Fangzhou partners with Tenry Pharmaceutical on diabetes care1
14.05.Fangzhou Inc.: Fangzhou and Tenry Pharmaceutical Forge Strategic Partnership to Advance AI-Powered Chronic Disease Care208SHANGHAI, May 14, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, and Shanghai Tenry Pharmaceutical...
► Artikel lesen
27.04.Fangzhou Inc.: Fangzhou Publishes 2025 Annual Report, Advancing AI-Powered Chronic Care Strategy for 2026413SHANGHAI, April 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. ("Fangzhou" or the "Company") (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, published its 2025 Annual Report...
► Artikel lesen
24.04.FANGZHOU JIANKE (06086): 2025 ANNUAL REPORT-
Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1